Lerner Research Institute Outcomes

Cleveland Clinic received 632 grant awards from federal institutions, including the National Institutes of Health and the Department of Defense, in 2023. This is 38 more than in 2022, a six percent increase.​

Cleveland Clinic received $188 million in awards from federal institutions in 2023. This is $17 million more than in 2022, almost a ten percent increase.​

Cleveland Clinic received $173 million in awards from the National Institutes of Health, the country’s largest federal funder of biomedical research, in 2023. This is $19 million more than in 2022, a 12 percent increase.​

Cleveland Clinic received $173 million in awards from the National Institutes of Health in 2023.

$94 million (54%) funded R01 grants, which support individual projects that align with Cleveland Clinic’s basic, translational and clinical research programs. These awards can be investigator-initiated or solicited via requests for application.

$16 million (9%) funded other types of R awards. These smaller, individual grants support early-stage research, research infrastructure, education programs and shared equipment.

$22 million (13%) funded P awards. P series grants, called program project/center grants, support teams of investigators conducting integrated, collaborative research projects and programs that have a well-defined, central research focus. In addition to individual research projects, they also provide support for shared resources.

$24 million (14%) funded U01 cooperative agreements. Like R01 grants, U01 grants support investigator-specific research projects and infrastructure. The major distinction is that cooperative agreements enable NIH to provide input on some decisions in collaboration with the principal investigator.

$17 million (10%) funded other types of grants, which primarily provide training and career support for early-stage investigators, including doctoral students, postdoctoral fellows and other trainees.